Filter posts

NIH, Patients and Industry Ramp Up to AMP-lify Innovation

Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading …

Expand Investment in Basic Research Needed to Advance Medical Progress

In 2007, the Napier and Lane families struggled to find answers to their daughters’ developmental …

BIO Testifies at 21st Century Cures Hearing on PCAST

Today, BIO’s Executive Vice President of Health Sara Radcliffe presented testimony to the U.S. House …

Driving Innovation through Federal Investments

Today, BIO submitted testimony to the Senate Committee on Appropriations on the importance of driving …

NIH & NSF SBIR/STTR Programs

Leveraging Small Business to Bring Life-Saving Innovations to the Market. A key part of the …

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, …

Congress Passes Omnibus Spending Agreement

This week, BIO President and CEO Jim Greenwood praised the Congress for passing the fundingbill …

SBIR Reauthorization Moves Forward

NIH has reissued its Small Business Innovation Research (SBIR) Omnibus Grant Solicitation announcement, which states …

Legislative Hopes, Fears

Biotechnology advances are poised now more than ever to help policymakers achieve their goals of …

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

I was recently asked what the single biggest threat to the biotechnology industry is today.  …